Stephane R B Heymans
Overview
Explore the profile of Stephane R B Heymans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Timmer L, den Hertog E, Versteeg D, Post H, Verdonschot J, Monshouwer-Kloots J, et al.
Cardiovasc Res
. 2025 Feb;
PMID: 39957251
Aims: In this study, we aimed to uncover genes associated with stressed cardiomyocytes by combining single-cell transcriptomic datasets from failing cardiac tissue from both humans and mice. Methods And Results:...
2.
Sikking M, Harding D, Henkens M, Stroeks S, Venner M, Nihant B, et al.
Circ Res
. 2024 Oct;
135(12):1193-1195.
PMID: 39429148
No abstract available.
3.
Stroeks S, Henkens M, Dominguez F, Merlo M, Hellebrekers D, Gonzalez-Lopez E, et al.
JACC Heart Fail
. 2024 Oct;
13(1):133-145.
PMID: 39425739
Background: Systemic immune-mediated diseases (SIDs) are a well-known cause of dilated cardiomyopathy (DCM), a cardiac phenotype influenced by genetic predispositions and environmental factors. Objectives: This study sought to examine if...
4.
Verdonschot J, Fuster J, Walsh K, Heymans S
Eur Heart J
. 2024 Oct;
PMID: 39417710
The increased sensitivity of novel DNA sequencing techniques has made it possible to identify somatic mutations in small circulating clones of haematopoietic stem cells. When the mutation affects a 'driver'...
5.
Verdonschot J, Heymans S, Van Linthout S
Eur J Heart Fail
. 2024 Sep;
26(10):2169-2172.
PMID: 39219297
No abstract available.
6.
Beijnink C, Raafs A, Vos J, Verdonschot J, Sikking M, Rodwell L, et al.
JACC Adv
. 2024 Aug;
3(8):101103.
PMID: 39105114
Background: Papillary muscle-delayed hyperenhancement (papHE) at cardiac magnetic resonance indicates fibrotic or infiltrative processes. Contrary to myocardial HE, the prevalence and prognostic implications of papHE in patients with nonischemic dilated...
7.
Weerts J, Raafs A, Sandhoefner B, van der Heide F, Mourmans S, Wolff N, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610657
Systemic microvascular regression and dysfunction are considered important underlying mechanisms in heart failure with preserved ejection fraction (HFpEF), but retinal changes are unknown. This prospective study aimed to investigate whether...
8.
Verdonschot J, Hellebrekers D, van Empel V, Heijligers M, de Munnik S, Coonen E, et al.
Circ Genom Precis Med
. 2024 Mar;
17(2):e004416.
PMID: 38516780
Background: Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (familial) genetic variants. PGT has been applied in inherited cardiac disease and is included in the latest...
9.
Sikking M, Stroeks S, Marelli-Berg F, Heymans S, Ludewig B, Verdonschot J
JACC Basic Transl Sci
. 2023 Dec;
8(11):1477-1488.
PMID: 38093747
Immunotherapy is a potential cornerstone in the treatment of myocardial fibrosis. During a myocardial insult or heart failure, danger signals stimulate innate immune cells to produce chemokines and profibrotic cytokines,...
10.
Verdonschot J, Heymans S
Eur Heart J
. 2023 Dec;
45(7):500-501.
PMID: 38085575
No abstract available.